Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

0.78
Delayed Data
As of Mar 04
 +0.0048 / +0.62%
Today’s Change
0.65
Today|||52-Week Range
1.52
+11.43%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
AssetsCash--9.9M13.5M18.7M
 
 
 
 
Short Term Investment Cash---2.5M3.6M5.2M
 
 
 
 
Cash & Short Term Investments14.8M11.8M13.6M18.8M
 
 
 
 
 
 
ReceivablesReceivables--18.7K0.000.00
 
 
 
InventoriesInventories--0.000.000.00--
 
Current AssetsPrepaid Expenses--163.3K12.8K507.2K
 
 
 
 
Other Current Assets--169.9K176.0K0.00
 
 
 
Current Assets--12.2M13.8M19.3M
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross--665.4K665.4K645.9K
 
 
 
 
Depreciation---570.8K-613.2K-580.7K
 
 
 
 
Other Assets--0.000.000.00--
Total Assets16.2M13.7M14.9M19.6M
 
 
 
 
 
 
LiabilitiesAccounts Payable--555.6K851.8K251.7K
 
 
 
 
Accrued Expenses--500.2K--240.6K
 
 
 
Other Current Liabilities--500.2K0.00240.6K
 
 
 
Other Liabilities--1.2M851.8K933.8K
 
 
 
 
 
Total LiabilitiesOther Liabilities5.8M973.1K4.5M5.1M
 
 
 
 
 
Total Liabilities5.8M3.0M5.4M6.9M
 
 
 
 
 
 
EquityMinority Interest--0.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity10.4M10.7M9.5M12.6M
 
 
 
 
 
Total Shareholder Equity10.4M10.7M9.5M12.6M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding84.2M95.3M119.4M146.7M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.
 

To view my watchlist

Not a member yet?

Sign up now for a free account